Oncoustics and Interson to bring AI Diagnostics, Guidance and Surveillance via Point-Of-Care
AI enabled systems enhance value for front line physicians and clinics to readily diagnose disease without referrals.
Oncoustics utilizes artificial intelligence to analyze raw ultrasound signals and consistently delineate healthy versus diseased tissue states in the liver and other anatomical regions. The first Oncoustics product will focus on the detection of liver fibrosis - an early predictor of progressive liver damage and mortality in patients with nonalcoholic fatty liver disease (NAFLD). The Interson/Oncoustics solution will be deployed to and tested in real-time clinical practice through collaborations already established by Oncoustics in the United States (US), Canada, China, Egypt and South Korea.
"NAFLD has reached epidemic proportions and is recognized as the most prevalent chronic liver disease in the world. In the US, NAFLD affects up to 30% of the population today", said Aijaz Ahmed, MD, a Transplant and General Hepatology clinican and professor at Stanford University with expertise and a research focus in NAFLD. "The team at Oncoustics are developing a portable screening and surveillance device for healthcare providers to facilitate early detection of patients with progressive liver disease in the setting of NAFLD, and with a focus to optimize individualized Precision Medicine," added Dr. Ahmed
"Oncoustics is pleased to be able to work with Interson and port our tissue characterization AI solution to their robust line of ultrasound products", said Ahmed El Kaffas, founder of Oncoustics. "The partnership with Interson gives us and our clinical partners an additional cost-effective solution for diagnosing diseases, triaging patients for further referral and providing point of care surveillance for those patients once diagnosed."
"This partnership with Oncoustics enables an additional AI layer on our Interson solutions and builds on our commitment to bring affordable, high-quality ultrasound tools to every medical professional"
For further information about Oncoustics:
Beth Rogozinski, COO
For further information about Interson:
Roman Solek, President & CEO